Trusted by 500+ global enterprises

Back

Free Security Reports

Gilead Sciences

Gilead Sciences is an American biopharmaceutical company headquartered in Foster City, California, United States. Founded in 1987 as Oligogen by Michael L. Riordan, it focuses on antiviral drugs for HIV/AIDS, hepatitis, influenza, and COVID-19. The company’s segments lude HIV (Biktarvy, Descovy), Liver Disease (Livdelzi, Epclusa), Oncology (Trodelvy, Yescarta), and Veklury (COVID-19 treatment). Gilead operates in over 35 countries, with 91% of U.S. product sales through three wholesalers (Cardinal Health, Cencora, McKesson), requiring robust third-party risk management (TPRM) for supply chain integrity under FDA, EMA, and GMP standards. Its TPRM program, per the 2024 10-K, ludes vendor audits for cybersecurity (NIST) and ethical sourcing, with $32 billion in planned U.S. manufacturing investments by 2030 to enhance supply resilience. Gilead acquired CymaBay Therapeutics in 2024 for $4.3 billion, adding seladelpar for PBC, and Interius BioTherapeutics for $350 million to advance CAR T-cell therapies. In Q2 2025, Gilead reported revenues of $7.1 billion, up 2% from Q2 2024, driven by HIV (up 7% to $5.1 billion) and Trodelvy (up 14% to $364 million), offset by Veklury’s 44% decline to $121 million. Non-GAAP EPS was $2.01, flat year-over-year.

Gilead Sciences Certifications and Compliance

Through Panorays’ Attack Surface Assessments, you can view all identified published certifications, providing a clearer and more accurate understanding of your compliance status

Privacy Policy Page

Gilead Sciences Cyber Related News

#1

Access business-specific cyber news from diverse sources, all categorized and consolidated in one place, ensuring clear visibility into cyber events and incidents relevant to your organization.

Gilead Sciences External Attack Surface Geolocation Map

Gain detailed insights into the location of your assets through our comprehensive external assessments.

Gilead Sciences Supply Chain Discovery

Supply Chain Discovery identifies Nth-party connections to your company, maps their relationships, and continuously monitors them for cyber threats. The following graph segments detected third parties according to their Cyber Posture Rating.

Gilead Sciences Cyber Posture Rating

Gilead Sciences security rating reflects the analysis of its external attack surface. A higher rating indicates a stronger security posture. Begin a free trial to receive a comprehensive risk assessment for Gilead Sciences.

Gilead Sciences Category Breakdown

Human

  • Employee
  • Security Team
  • Social Posture
  • Dynamics

Application

  • Techs
  • Application Security
  • Domain Attacks
  • Exposed Services

IT

  • DNS
  • Mail Server
  • Asset Reputation
  • Web Server
  • TLS
  • Cloud
  • Endpoint

Panorays is a Leader in The Forrester Wave in Cybersecurity Risk Ratings Platforms, 2026

Panorays is a Leader

“Panorays stands out with one of the most ambitious roadmaps and innovation driven approaches to agentic AI in this evaluation…”

Read More Security Reports

Is your organization secure?